Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Malick Minkael Sylla"'
Autor:
Malick Minkael Sylla, Alexandre Delamou, Alassane Dicko, A. Touré, Abdoul Habib Beavogui, Issaka Sagara, Ahmadou Hamidou Togo, Daouda Camara, Abdoulaye Djimde, Abdoulaye Doumbouya, Sekou Toure, Mamadou Saliou Diallo
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
Guinea’s reference ranges for biological parameters rely on those of Caucasian values. Variability in reference ranges according to the context is well-documented. We conducted this study for the purpose of future malaria clinical trials that asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec15d3d274d86ebe5d7bec69905b0358
https://doi.org/10.1155/2020/8605485
https://doi.org/10.1155/2020/8605485
Autor:
Sekou Toure, Mahamoud Sama Cherif, Issaka Sagara, Mamadou Saliou Diallo, Karifa Kourouma, Abdoul Habib Beavogui, Elisabeth Y. Diawara, Amadou Hamidou Togo, Pascal Millimouno, Alexandre Delamou, Abdoulaye Djimde, Daouda Camara, Malick Minkael Sylla, Alhassane Dicko, Nouhoum Diallo, Gnepou Camara, Aliou Traore, A. Touré
Publikováno v:
The Journal of parasitology. 107(5)
The use of Amodiaquine monotherapy is associated with the selection of molecular markers of Plasmodium falciparum resistance to chloroquine (pfcrt and pfmdr1). The decrease in sensitivity and the emergence of P. falciparum resistant to artemisinin-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc01495fc850727ddb69569d06b83876
https://pubmed.ncbi.nlm.nih.gov/34581793
https://pubmed.ncbi.nlm.nih.gov/34581793
Autor:
Issiaka Soulama, Oumar B Traore, Désiré Kargougou, Malick Minkael Sylla, Hamadoun Diakite, Anders Björkman, San Maurice Ouattara, Boubou Sangare, Edith C Bougouma, Amidou Diarra, Harouna Soré, Frederic Nikiema, Sodiomon B. Sirima, Aissata Barry, Aboubacar S Coulibaly, Niawanlou Dara, Abdoul Habib Beavogui, Stéphane Picot, Anyirékun Fabrice Somé, Stephan Duparc, Abdoulaye Djimde, Steffen Borrmann, Ogobara K. Doumbo, Robert M Miller, Amadou H Togo, Samba Coumare, Noelie Henry, Bouran Sidibe, Issaka Sagara, Siaka Goita, Jean-Bosco Ouédraogo, Moise Kabore, Hamma Maiga, Issaka Zongo, José Pedro Gil, Mamadou Saliou Diallo, Jangsik Shin, Mohamed Lamine Alhousseini, Moctar Coulibaly, Bakary Fofana, Hamidou Niangaly, Moussa Djimde, Alassane Dicko, Colin J. Sutherland, Nouhoum Diallo, Isabelle Borghini-Fuhrer, Daouda Camara, Mohamed Keita, Yves D Compaore, Sekou Koumare, Modibo Diarra, Aliou Traore, Souleymane Dama, Amadou Bamadio, Ismaila Thera, Francois Dao
Publikováno v:
The Lancet
The Lancet, Elsevier, 2018, 391 (10128), pp.1378-1390. ⟨10.1016/S0140-6736(18)30291-5⟩
Lancet (London, England)
The Lancet, Elsevier, 2018, 391 (10128), pp.1378-1390. ⟨10.1016/S0140-6736(18)30291-5⟩
Lancet (London, England)
Summary Background Artemether–lumefantrine and artesunate–amodiaquine are used as first-line artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate and dihydroartemisinin–piperaquine are potentially useful for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75919a3d04b1b4cc23db33e4cac40681
https://hal-udl.archives-ouvertes.fr/hal-02136477
https://hal-udl.archives-ouvertes.fr/hal-02136477
Autor:
Oumar B Traore, Jean-Bosco Ouédraogo, Daouda Camara, Jangsik Shin, Isabelle Borghini-Fuhrer, Ogobara K. Doumbo, Malick Minkael Sylla, Abdoul Habib Beavogui, Issaka Zongo, Steffen Borrmann, Frederic Nikiema, Sodiomon B. Sirima, Aboubacar S Coulibaly, José Pedro Gil, Mamadou Saliou Diallo, Alassane Dicko, Ismaila Thera, Niawanlou Dara, Anyirékun Fabrice Somé, Stephan Duparc, Moise Kabore, Robert M Miller, Issiaka Soulama, Abdoulaye Djimde, Issaka Sagara, Bakary Fofana, Yves D Compaore, Anders Björkman
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-artesunate after treatment of the first episode of malari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d223048b4d02a8707adcb6d988e9de3a
https://pubmed.ncbi.nlm.nih.gov/26601737
https://pubmed.ncbi.nlm.nih.gov/26601737